logo

You are here

Warning message

Attention! This event has already passed.

Ethics Week 2019 - Lunch Session 5 "Ethics & Biomedical Sciences"

Thursday, 5 December, 2019 - 12:00
Campus: Brussels Health Campus
R
Atrium / Forum
Research events
+32 2 629 21 49
john.pearson@vub.be
https://www.vub.be/weekvandeethiek

The students from the Research Master's Programme in Biomedical Sciences will organise a session on ethics questions in their research. They will look at two topics:

One shot to save the world

 We all feel protected from diseases such as polio and the measles, but what happens when people stop vaccinating? Will children start dying again from diseases that we (almost) completely eradicated years ago? Should we make vaccines mandatory to ensure that that will not happen?

This session will look at the possibility of making vaccines mandatory and problems we might encounter during this journey. Topics that be will be discussed include:

-    Will all vaccines be mandatory?

-    What about religious exemptions?

-    Will there be repercussions for not vaccinating and if so, what kind of repercussions?

-   Should we ban anti-vax websites and social media accounts?

-  Should people who bring out non-evidence-based claims about vaccination be punished?

Egg Freezing

Oocyte cryopreservation, sometimes referred to as egg freezing, is a process where a women’s oocytes, or egg cells, are isolated, frozen and stored to preserve their reproductive potential. Thus In this manner, cryopreservation is a technique that can be used to extend the fertility of elderly women. Another use for this method is for women diagnosed with certain diseases or undergoing treatments that can damage their fertility. Oocyte retrieval is permitted by Belgian law up to the age of 46, whereas the transfer of oocytes is permitted up to the age of 48. Is this arbitrarily determined cut-off age practical or not? To what extent does it cover the whole female population? Which laws are put in place for patients who undergo fertility-damaging diseases or treatments, and how well are women who choose for cryopreservation informed on the matter? As of late, the insurance (National Institute for Health and Disability Insurance) refunds one round of oocyte cryopreservation for cancer patients before their 38th birthday. Shouldn’t this refund be available for all patients suffering fertility-damaging diseases or treatments? To what extent should the government intervene, both in healthy and ill women? Nevertheless it is worth investigating how many of the preserved oocytes are eventually transferred. Tying in with this, is another matter of great importance: what to do with the remaining, untouched oocytes?

Professor Michel De Vos of the Centre for Reproductive Medicine will participate in this session.

 

 

 

 

 

You can no longer submit using form.